AASLD The Liver Meeting
The American Association for the Study of Liver Disease (AASLD) 2025 Liver Meeting will take place in Washington, DC from November 7–11, 2025. The meeting will feature research, educational sessions, and collaborative forums.
Conference Highlights
Expert Interviews
Featured
More Timely Care for Chronic Liver Disease is Coming, Step-by-Step, says Hepatologist Bruce Luxon, MD, PhD
Grace Halsey
December 4 2023
To Help Reduce the Burden of Chronic Liver Disease, Primary Care Needs Simple, Reliable, Available Tools
Grace Halsey
December 4 2023
10 Top Studies from The Liver Meeting 2023: At-a-Glance
Grace Halsey
December 1 2023
Underestimation of OHE Hospitalizations: Author of New Study Discusses Clinical Implications, Takeaways for Primary Care Clinicians
Sydney Jennings
November 29 2023
Speech May be a Promising Biomarker for MHE, OHE, According to New Research
Grace Halsey
November 13 2023
How to Change the Course of Chronic Liver Disease in the US: Create a Groundswell Movement
Grace Halsey
November 13 2023
NASH Diagnosis: Patients Overwhelmed But Motivated to Adhere to Guidance and Want More Help, Survey Finds
Grace Halsey
November 12 2023
Cloud-Based "Liver Toolkit" Identifies Primary Care Patients at High Risk for Fibrosis, Requiring Referral
Grace Halsey
November 11 2023
FIB-4 Risk-Stratification Algorithm for MASLD Improved Primary Care Practice Patterns, According to New Research
Sydney Jennings
November 10 2023
New Data Show Rise in Decompensated Cirrhosis and Hepatic Encephalopathy Cases among US Medicare Beneficiaries
Sydney Jennings
November 10 2023
New NAFLD Familial Risk Score Outperforms FIB-4 for Predicting Advanced Fibrosis in First-Degree Relatives
Grace Halsey
November 10 2023
Novel Algorithm, FAST-3, Shows Promise as Noninvasive Classifier for Advanced Fibrosis in MASLD
Grace Halsey
November 10 2023
Hepatic Steatosis is a Risk Factor for MACE, Even Among Individuals at Low 10-Year ASCVD Risk
Grace Halsey
November 10 2023
Rifaximin Significantly Reduced Recurrent OHE and Associated Health Care Utilization
Grace Halsey
November 10 2023
Statin Protection Against Cirrhosis in Adults with NAFLD More Pronounced with Age
Grace Halsey
November 10 2023
New Research Reveals Underestimation of Overt Hepatic Encephalopathy Hospitalizations in US
Sydney Jennings
November 10 2023
STUDY: Novel “Triagonist” Retatrutide Resolved Steatosis in Over 85% of Patients with MASLD and Obesity
Sydney Jennings
November 10 2023
It's High Time to Retire NAFLD: Multinational Liver Societies Explain
Grace Halsey
November 8 2023
NAFLD is Now MASLD: The New Nomenclature, At-a-Glance
Grace Halsey
November 8 2023
The Liver Meeting 2023: AASLD Offers "Journey Maps" to Focused Areas of Interest
Grace Halsey
November 6 2023
